DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that Company management will participate in the 33rd Annual ROTH Conference, which will be held virtually on March 15-17, 2021.
Investors interested in arranging a virtual meeting with the Company’s management on Wednesday, March 17, should contact the ROTH conference coordinator or [email protected].
Headquartered in Devon, Zynerba Pharmaceuticals is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.